The central message of the EASO 2026 update is clear: obesity should be managed as a chronic systemic disease, and therapeutic success should be measured by improvements in overall health and reduction of complicationsnot solely by the percentage of weight loss achieved
Side Effects and How They Are Managed Side effects of Qsymia may include dry mouth, mild tingling sensations, altered taste, constipation, or difficulty sleeping if taken too late in the day
What happens when you stop Research consistently shows that most patients regain some or all of their lost weight after stopping GLP-1 medications unless they have built sustainable lifestyle habits during treatment
Its a great choice for those seeking daily digestive support with added benefits for appetite control.* Should I take both Flatter Me and Flatter Me Fiber
retatrutide is a GIP/GLP-1/glucagon triple agonist (appetite plus energy expenditure)
It holds particular promise for those seeking deeper weight loss and broader health gains, she adds